Drug induces morphologic, molecular and clinical remissions in myelofibrosis

Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found.

http://medicalxpress.com/news/2013-12-drug-morphologic-molecular-clinical-remissions.html